Wuhan
688526.SSWuhan Keqian Biology Co.,Ltd Price (688526.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
465,805,821
(0.0954)%Cash Flow Statement
Wuhan Keqian Biology Co.,LtdCurrency: CNY
| YEAR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||
| Net Income | 186.17M
+0% |
320.31M
+72% |
388.91M
+21% |
242.64M
-38% |
447.80M
+85% |
570.64M
+27% |
409.15M
-28% |
395.58M
-3% |
|||||||||||
| Depreciation And Amortiz... | 19.16M | 23.44M | 34.70M | 37.15M | 37.03M | 62.64M | 97.69M | 114.27M | |||||||||||
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 2.95M | -297,982.00 | 16.16M | 16.64M | 0.00 | |||||||||||
| Stock-Based Compensat... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Change In Working Capital | |||||||||||||||||||
| Accounts Receivables | 0.00 | -51,732,692.00 | -38,607,619.00 | -53,236,286.00 | -123,294,007.00 | -118,719,990.00 | -134,357,814.00 | -19,847,843.00 | |||||||||||
| Accounts Payables | 0.00 | 0.00 | 0.00 | -58,014,105.00 | 72.55M | 77.77M | 121.36M | 15.15M | |||||||||||
| Inventory | -3,466,548.13 | -31,443,337.62 | -11,885,042.44 | 7.08M | -10,025,918.74 | -38,498,877.31 | -67,962,093.10 | 8.81M | |||||||||||
| Other Working Capital | 19.06M | 28.93M | -37,528,684.06 | 2.95M | -297,981.65 | 16.16M | 16.64M | -17,368,944.38 | |||||||||||
| Other Non-Cash Items | -226,831.53 | -3,628,911.47 | -22,368,480.50 | -23,676,566.56 | -23,623,572.61 | -38,718,371.83 | -18,805,076.39 | 41.44M | |||||||||||
| Net Cash Provided By Op... | 220.69M
+0% |
337.61M
+53% |
351.83M
+4% |
154.89M
-56% |
400.14M
+158% |
531.27M
+33% |
423.71M
-20% |
538.03M
+27% |
|||||||||||
| Investing Activities | |||||||||||||||||||
| Investments In Propert... | -29,129,629.06 | -129,113,879.49 | -31,421,489.76 | -137,735,679.53 | -111,595,863.27 | -374,445,603.36 | -102,851,038.27 | -104,504,192.00 | |||||||||||
| Acquisitions Net | 29.13M | 129.11M | 0.00 | 137.74M | 111.63M | 545.00k | -8,460,936.05 | -4,050,000.00 | |||||||||||
| Purchases Of Investments | -90,000,000.00 | -807,000,000.00 | -1,207,000,000.00 | -1,261,050,000.00 | -1,783,400,000.00 | -1,113,000,000.00 | -1,439,750,200.00 | -2,264,308,164.00 | |||||||||||
| Sales Maturities Of Inve... | 121.92M | 436.45M | 1.55B | 775.06M | 704.67M | 1.16B | 913.85M | 1.98B | |||||||||||
| Other Investing Activities | -29,129,629.06 | -129,113,879.49 | 11.68M | -137,735,679.00 | -111,595,862.36 | -544,999.91 | 84.42k | 61.00M | |||||||||||
| Net Cash Used For Inv... | 2.79M
+0% |
-499,664,522.64
-17,977% |
323.03M
-165% |
-623,723,058.53
-293% |
-1,190,296,224.63
+91% |
-331,100,328.27
-72% |
-637,127,323.29
+92% |
-328,996,172.00
-48% |
|||||||||||
| Financing Activities | |||||||||||||||||||
| Debt Repayment | -4,000,000.00 | 0.00 | 0.00 | 0.00 | 60.00M | 17.99M | 193.51M | 13.66M | |||||||||||
| Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Common Stock Repurch... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Dividends Paid | -30,024,383.33 | -47,245,476.38 | -122,279,586.72 | -85,752,253.91 | -368,958.33 | -134,850,000.00 | -88,375,308.00 | -97,085,536.00 | |||||||||||
| Other Financing Activities | -6,002.00 | -2,550,004.88 | 1.56M | 0.91 | 1.15B | -4,321,741.00 | 8.39M | -19,002,987.00 | |||||||||||
| Net Cash Used/Provide... | -34,030,385.03
+0% |
-49,795,480.88
+46% |
-120,717,315.62
+142% |
-85,752,253.91
-29% |
1.21B
-1,506% |
-121,181,741.66
-110% |
113.52M
-194% |
-102,425,360.00
-190% |
|||||||||||
| Effect Of Forex Changes... | 0.00 | 0.00 | 0.62 | 0.28 | 0.00 | -0.07 | 1.11 | 54.93k | |||||||||||
| Net Change In Cash | 189.46M | -211,848,157.00 | 554.15M | -554,586,901.00 | 415.56M | 78.99M | -99,894,077.00 | 106.67M | |||||||||||
| Cash At Beginning Of Per... | 78.87M | 268.33M | 56.48M | 610.63M | 56.04M | 471.61M | 550.60M | 450.70M | |||||||||||
| Cash At End Of Period | 268.33M | 56.48M | 610.63M | 56.04M | 471.61M | 550.60M | 450.70M | 557.37M | |||||||||||
| Additional Metrics: | |||||||||||||||||||
| Operating Cash Flow | 220.69M | 337.61M | 351.83M | 154.89M | 400.14M | 531.27M | 423.71M | 538.03M | |||||||||||
| Capital Expenditure | -29,129,629.06 | -129,113,879.49 | -31,421,489.76 | -137,735,679.53 | -111,595,863.27 | -374,445,603.36 | -102,851,038.27 | -104,504,192.57 | |||||||||||
| Free Cash Flow | 191.56M
+0% |
208.50M
+9% |
320.41M
+54% |
17.15M
-95% |
288.54M
+1,582% |
156.82M
-46% |
320.86M
+105% |
433.53M
+35% |
|||||||||||